Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.

[1]  G. Magnusson,et al.  2-Bromoethyl glycosides: synthesis and characterisation , 1983 .

[2]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[3]  J. V. Alstine,et al.  Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. , 1995, Journal of biomedical materials research.

[4]  J. Kihlberg,et al.  Preparation of building blocks for glycopeptide synthesis by glycosylation of Fmoc amino acids having unprotected carboxyl groups , 1995 .

[5]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[6]  A. R. Srinivasan,et al.  Modulation of nucleic acid structure by ligand binding: induction of a DNA.RNA.DNA hybrid triplex by DAPI intercalation. , 1997, Bioorganic & medicinal chemistry.

[7]  G. A. van der Marel,et al.  Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. , 1999, Journal of medicinal chemistry.

[8]  J. Kihlberg,et al.  Deacetylation of Nα-methylated glycopeptides reveals that aza-enolates provide protection against β-elimination of carbohydrates O-linked to serine , 2000 .

[9]  Y. Aoyama,et al.  Saccharide-Directed Cell Recognition and Molecular Delivery Using Macrocyclic Saccharide Clusters: Masking of Hydrophobicity to Enhance the Saccharide Specificity , 2000 .

[10]  M. Léonard,et al.  Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique. , 2000, Journal of biomedical materials research.

[11]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[12]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001 .

[13]  P. Couvreur,et al.  Polysaccharides Grafted with Polyesters: Novel Amphiphilic Copolymers for Biomedical Applications , 2002 .

[14]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[15]  P. Couvreur,et al.  Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[16]  P. Couvreur,et al.  Novel Polyester-Polysaccharide Nanoparticles , 2003, Pharmaceutical Research.

[17]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[18]  Ruxandra Gref,et al.  Polysaccharide-decorated nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Robert Gurny,et al.  Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  V. Venkateswarlu,et al.  Novel delivery systems for drug targeting to the brain , 2004 .

[21]  T. V. van Berkel,et al.  Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor. , 2004, Journal of medicinal chemistry.

[22]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[23]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[24]  S. Lesieur,et al.  Physico-chemical characterization of polysaccharide-coated nanoparticles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[25]  G. Tosi,et al.  Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[26]  L. Yahia,et al.  Therapeutic potential of nanoparticulate systems for macrophage targeting. , 2005, Biomaterials.

[27]  R. Müller,et al.  Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.